DOCSLIB.ORG

Comparative Study of Enema Retention and Preference in Ulcerative Colitis J R Ingram, J Rhodes, B K Evans, R G Newcombe, G a O Thomas

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Comparative Study of Enema Retention and Preference in Ulcerative Colitis J R Ingram, J Rhodes, B K Evans, R G Newcombe, G a O Thomas 594 Postgrad Med J: first published as 10.1136/pgmj.2004.031690 on 2 September 2005. Downloaded from ORIGINAL ARTICLE Comparative study of enema retention and preference in ulcerative colitis J R Ingram, J Rhodes, B K Evans, R G Newcombe, G A O Thomas ............................................................................................................................... Postgrad Med J 2005;81:594–598. doi: 10.1136/pgmj.2004.031690 Background: Therapeutic enemas are often used to treat active colitis but their retention may be limited because of urgency to defecate. Some preparations may be better retained and tolerated than others See end of article for because of their physical properties. authors’ affiliations ....................... Aim: To compare patient preference and retention of four therapeutic enemas, including a nicotine enema, in patients with ulcerative colitis (UC). Correspondence to: Methods: Twenty four patients with active UC received the four trial enemas—corticosteroid, 5-amino Dr G A O Thomas, Department of salicylate (5-ASA), and nicotine liquid enemas and a corticosteroid foam, in a randomised order, taking Gastroenterology, one enema on each of four successive nights. Patients scored them 1 to 4 for ease of administration and University Hospital of retention, degree of abdominal bloating, and for their overall preference. Wales, Heath Park, Cardiff CF14 4XW, UK; Gareth. Results: Fifteen patients rated nicotine their overall favourite or second favourite, compared with 14 for [email protected]. corticosteroid foam and 11 for 5-ASA and corticosteroid liquids, but this was not significant (p = 0.302). nhs.uk Overall, there was no significant difference in overnight retention. However, the nicotine enema tended to be less well retained in patients with milder urgency but a higher proportion retained it overnight with Submitted 16 December 2004 more severe urgency (p = 0.031 compared with 5-ASA enema). Accepted 8 March 2005 Conclusion: There was no significant difference in patient preference or overall duration of retention for ....................... the four enemas. hile therapeutic enemas are useful in the manage- in the stool—these are often perceived by patients to be the ment of patients with inflammatory bowel disease1–6 most troublesome symptoms. Sigmoidoscopy was not per- Wpoor retention can limit their effect, particularly in formed as the purpose of the score was simply to ensure that patients with active disease associated with urgency of all patients had symptomatically active disease on entry to defecation. Enemas may be retained for only short periods, the study. All gave written informed consent before and in some cases much of the enema may be passed soon participation in the study, which was approved by the after administration. Fear of incontinence while in bed is also South East Wales Local Research Ethics Committee. a problem. Subjects were excluded if they were known to be intolerant During a study of liquid nicotine enemas as treatment for of any of the trial medication, and those who might have ulcerative colitis (UC),7 some patients commented on how been pregnant or were lactating. http://pmj.bmj.com/ readily it was retained—and without discomfort. To examine the hypothesis that nicotine enemas may be better retained, Trial enemas we compared the retention of nicotine enemas with three Three liquid preparations, each about 100 ml in volume, were others, all conventionally used in the treatment of colitis— packaged in identical soft low density polyethylene bottles two of them liquid enemas and one foam enema. The aim of (Forrest Labs, Bexley, UK), together with one foam enema; the study was limited to identification of the patients’ their compositions are below: preference for each enema and duration of retention in on October 2, 2021 by guest. Protected copyright. subjects with active UC—efficacy was not considered. In (1) The prednisolone sodium phosphate liquid enema doing so we used a novel design in which patient preference (Predsol, Celltech) was an aqueous formulation with a was based on exposure to each enema, once only on viscosity of 0.39 mPas, containing 20 mg of prednisolone consecutive nights—a design that breaks with traditional as the sodium phosphate ester in a buffered solution. comparisons in which efficacy is an issue. Included in the formulation are methyl, ethyl, propyl, and butyl 4-hydroxybenzoates as preservatives, disodium METHODS edentate as a chelating agent, sodium acid phosphate Subjects and disodium hydrogen phosphate as buffering agents, A total of 40 consecutive patients, attending the colitis clinic, and sodium hydroxide to adjust its pH to 6.3. who fulfilled diagnostic criteria for UC with active symptoms, (2) The 5-amino salicylate (5-ASA) liquid enema (Pentasa, were reviewed and considered for the study. Twenty four of Ferring Pharma) was an aqueous suspension, pH 4.6 and these patients who required topical treatment were recruited viscosity 0.49 mPas, containing 1 g of mesalazine in to the study. The principal reasons for patients not distilled water. It also contains sodium metabisulphite as participating were unsuitability for topical treatment or an antioxidant. patients declining to take part. The severity of disease on (3) The nicotine liquid enema (SLA Pharma, Watford, UK) entry to the trial was assessed according to a composite was an aqueous formulation that contained 6 mg of scoring system based on the ulcerative colitis disease Activity nicotine base (Seigfried Labs, Zofingen, Switzerland) Index (UCDAI)2 (see box). This composite score was derived from symptoms only; it included stool frequency and Abbreviations: UC, ulcerative colitis; AE, adverse event; UCDAI, consistency, urgency to defecate, and the presence of blood ulcerative colitis disease activity index; 5-ASA, 5-amino salicylate www.postgradmedj.com Enema retention in ulcerative colitis 595 Postgrad Med J: first published as 10.1136/pgmj.2004.031690 on 2 September 2005. Downloaded from Composite score of disease activity Table 1 Demographic details of subjects Sex Stool frequency M/F 13/11 Age, years N 0; usual number of stools for this patient Mean/range 45.1/19–84 N 1; 1–2 stools per day more than usual Extent of colitis Rectal 6 N 2; 3–4 stools per day more than usual Rectosigmoid 7 N 3; at least 5 stools per day more than usual Left sided 6 Total 4 Stool consistency Unknown 1 Previous enema use N 0; formed Yes/no 23/1 N 1; loose Current topical treatment on trial entry None 15 N 2; watery Foam 5 Liquid 3 Urgency of defecation, Suppository 1 N Concomitant oral drugs 0; none 5-ASA 14 N 1; mild Prednisolone 6 N 2; moderate Thiopurines 6 Smoking status N 3; severe (including incontinence) Non/former 11/13 Rectal bleeding N 0; none N 1; streaks of blood with stools less than half the time N 2; obvious blood with stools most of the time power may actually be greater than for 96 different patients N 3; blood alone passed receiving only one treatment as a subject’s responses to different, comparable treatments usually produces positive Maximum total score = 11 correlation when they rank the treatments in order of Adapted from Sutherland et al.2 preference. Subjects were advised to administer enemas slowly and in a consistent way—lying on their side in the left lateral decubitus position, after first warming the enema to body complexed to 400 mg of carbomer powder (Carbopol temperature. They were asked to record their preferences for 974P, Noveon, Cleveland, OH).8 The addition of 100 mg each enema on a diary card and were interviewed either in of xanthan gum (Keltrol, Kelco) made the enema clinic or by telephone after one week. thixotropic and increased its viscosity. Trometamol, TRIS, (S Banner and Son, UK), served as a buffer to Evaluation procedures produce a solution of pH 5.2 with a viscosity of In each case, patients were asked whether the enema was 172 mPas.910 initially retained and then whether it was retained over- night—defined as at least eight hours; if less than the whole (4) The Predfoam enema (Pharmax) was a white mucoad- http://pmj.bmj.com/ night, the duration of enema retention was recorded. They herent aerosol foam, with a dynamic viscosity of also recorded any associated adverse events (AEs). Patients 5.7 mPas and pH of 4.8, which contained prednisolone ranked each of the four enemas, scoring them 1 to 4 for ease metasulphobenzoate sodium, equivalent to 20 mg of of administration, ease of retention both initially and prednisolone per metered dose of about 50 ml. The overnight, degree of any abdominal bloating, and for their product also contained disodium edentate as a chelating overall preference. agent, phenoxyethanol and sorbic acid as preservatives, and propellant gases. Statistical analysis on October 2, 2021 by guest. Protected copyright. Preference scores were compared between enemas using ‘‘Latin square’’ study design and sample size three way analysis of variance modelling by subject, period, Patients who required or were already taking topical and enema. Proportions with initial retention were compared treatment for their colitis were given the four trial enemas between groups by the x2 test. Proportions achieving full in a randomised order, taking one enema on each of four overnight retention were compared by the McNemar test, successive nights. A washout period between enemas was not taking the mid-p two tailed p value and setting significance included as this would have introduced a time delay between at the conventional 5% level. A sub-analysis of the effect of enemas, allowing changes in disease severity to affect the urgency on overnight retention was performed and the results. Twenty four subjects were entered into a Latin square results interpreted cautiously. design in which all permutations of the order of enema administration were included once only; this ensured that RESULTS any carryover effect of earlier enemas affecting subsequent All 24 subjects recruited, 13 male, with a mean age of 45 ones, either by clinical improvement or rectal irritation, did years, completed the study.
Load more

Recommended publications
  • Gel-Syn™ Product Information Caution
    GEL-SYN™ PRODUCT INFORMATION CAUTION: Federal law restricts this device to sale by or on the order of a physician (or properly licensed practitioner). CONTENT Each 1 mL of Gel-Syn contains: Sodium Hyaluronate: 8.4 mg Sodium Chloride: 8.5 mg Sodium Phosphate, Dibasic: 0.16 mg Sodium Phosphate, Monobasic: 0.045 mg Water for Injection: q.s. to 1.0 mL DESCRIPTION Gel-Syn is a sterile, buffered solution of highly purified sodium hyaluronate with a molecular weight of approximately 1100 kDa, obtained through fermentation of Streptococci of Lancefield groups A and C and chemically unmodified. INDICATION Gel-Syn is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). CONTRAINDICATIONS • Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. • Do not inject Gel-Syn into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site. WARNINGS • Do not concomitantly use disinfectants containing quaternary ammonium salts for skin preparation because sodium hyaluronate can precipitate in their presence. • Inject into the synovial space only. Do not inject by intravascular route. • Do not inject outside the synovial space or into the synovial tissue or capsule. An extra- articular injection of the product can cause local adverse events. PRECAUTIONS General • The safety and effectiveness of Gel-Syn in locations other than the knee, and for conditions other than osteoarthritis, have not been established. • Strict aseptic administration technique must be followed.
    [Show full text]
  • Rectal Suppository & Enema Administration to Administration Unlicensed Assistive Personnel (UAP) Module/Skill Checklist
    Delegation of Medication Rectal Suppository & Enema Administration to Administration Unlicensed Assistive Personnel (UAP) Module/Skill Checklist Objective At the completion of this module, the UAP should be able to administer rectal suppository & enema medications. NOTE: 1) The RN or LPN is permitted to delegate ONLY after application of all components of the NCBON Decision Tree for Delegation to UAP and after careful consideration that delegation is appropriate: a) for this client, b) with this acuity level, c) with this individual UAP’s knowledge and experience, and d) now (or in the time period being planned). 2) Successful completion of the “Infection Control” module by the UAP should be documented prior to instruction in medication administration by this or ANY route. Procedure for: SUPPOSITORY 1. Perform skills in General Medication Administration Checklist. 2. Provide privacy. Have client void before procedure. 3. Put on clean gloves. 4. Position the client on their left (preferred) side with the top leg bent slightly. 5. Remove the foil or wrapper from the suppository, if present. 6. Apply a small amount of lubricant to the suppository and your gloved index finger on your dominant hand – the hand holding the suppository. 7. Separate the buttocks with your gloved, non dominant hand. 8. Ask the client to breathe slowly and deeply through the mouth. 9. Place tip of suppository against anus and gently insert the suppository about 4- inches along the rectal wall. Avoid putting the suppository in stool. 10. After removing your finger, squeeze buttocks together for a few minutes to help client hold in the suppository for as long as possible.
    [Show full text]
  • Physical-Chemical Characteristics of Whitening Toothpaste and Evaluation of Its Effects on Enamel Roughness
    Dental materials Physical-chemical characteristics of whitening toothpaste and evaluation of its effects on enamel roughness Sérgio Paulo Hilgenberg(a) Abstract: This in vitro study evaluated the physical-chemical characteris- (a) Shelon Cristina Souza Pinto tics of whitening toothpastes and their effect on bovine enamel after ap- Paulo Vitor Farago(b) Fábio André Santos(a) plication of a bleaching agent (16% carbamide peroxide). Physical-chem- Denise Stadler Wambier(a) ical analysis was made considering mass loss by desiccation, ash content and pH of the toothpastes. Thirty bovine dental enamel fragments were prepared for roughness measurements. The samples were subjected to (a) Department of Dentistry, School of Dentistry, Ponta Grossa State University, bleaching treatments and simulated brushing: G1. Sorriso Dentes Brancos Ponta Grossa, PR, Brazil. (Conventional toothpaste), G2. Close-UP Whitening (Whitening tooth- (b) Department of Pharmacy, School of paste), and G3. Sensodyne Branqueador (Whitening toothpaste). The av- Dentistry, Ponta Grossa State University, erage roughness (Ra) was evaluated prior to the bleaching treatment and Ponta Grossa, PR, Brazil. after brushing. The results revealed differences in the physical-chemical characteristics of the toothpastes (p < 0.0001). The final Ra had higher values (p < 0.05) following the procedures. The mean of the Ra did not show significant differences, considering toothpaste groups and bleach- ing treatment. Interaction (toothpaste and bleaching treatment) showed significant difference
    [Show full text]
  • An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: a Review
    Muthadi Radhika Reddy /J. Pharm. Sci. & Res. Vol. 12(7), 2020, 925-940 An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: A Review Muthadi Radhika Reddy1* 1School of pharmacy, Gurunanak Institute of Technical Campus, Hyderabad, Telangana, India and Department of Pharmacy, Gandhi Institute of Technology and Management University, Vizag, Andhra Pradesh, India INTRODUCTION 2. Useful in situations where rapid onset of action Fast dissolving drug delivery systems were first developed required such as in motion sickness, allergic attack, in the late 1970s as an alternative to conventional dosage coughing or asthma forms. These systems consist of solid dosage forms that 3. Has wide range of applications in pharmaceuticals, Rx disintegrate and dissolve quickly in the oral cavity without Prescriptions and OTC medications for treating pain, the need of water [1]. Fast dissolving drug delivery cough/cold, gastro-esophageal reflux disease,erectile systems include orally disintegrating tablets (ODTs) and dysfunction, sleep disorders, dietary supplements, etc oral thin films (OTFs). The Centre for Drug Evaluation [4] and Research (CDER) defines ODTs as,“a solid dosage 4. No water is required for the administration and hence form containing medicinal substances which disintegrates suitable during travelling rapidly, usually within a matter of seconds, when placed 5. Some drugs are absorbed from the mouth, pharynx upon the tongue” [2]. USFDA defines OTFs as, “a thin, and esophagus as the saliva passes down into the flexible, non-friable polymeric film strip containing one or stomach, enhancing bioavailability of drugs more dispersed active pharmaceutical ingredients which is 6. May offer improved bioavailability for poorly water intended to be placed on the tongue for rapid soluble drugs by offering large surface area as it disintegration or dissolution in the saliva prior to disintegrates and dissolves rapidly swallowing for delivery into the gastrointestinal tract” [3].
    [Show full text]
  • Acrylamide Polymerization — a Practical Approach
    electrophoresis tech note 1156 Acrylamide Polymerization — A Practical Approach Paul Menter, Bio-Rad Laboratories, 2000 Alfred Nobel Drive, Polyacrylamide Gel Polymerization Hercules, CA 94547 USA AcrylamideBis Polyacrylamide Introduction The unparalleled resolution and flexibility possible with CH2 CH + CH2 CH CH2 CH CH2 CH CH2 CH polyacrylamide gel electrophoresis (PAGE) has led to its CO CO CO CO CO widespread use for the separation of proteins and nucleic NH2 NH NH2 NH2 NH acids. Gel porosity can be varied over a wide range to meet CH2 CH2 specific separation requirements. Electrophoresis gels and NH NH NH NH buffers can be chosen to provide separation on the basis of CO 2 2 CO CO C O charge, size, or a combination of charge and size. CH2 CH CH2 CH CH2 CH CH2 CH The key to mastering this powerful technique lies in the polymerization process itself. By understanding the important Purity of Gel-Forming Reagents parameters, and following a few simple guidelines, the novice Acrylamide can become proficient and the experienced user can optimize Gel-forming reagents include the monomers, acrylamide and bis, separations even further. as well as the initiators, usually ammonium persulfate and TEMED or, occasionally, riboflavin and TEMED. On a molar This bulletin takes a practical approach to the preparation of basis, acrylamide is by far the most abundant component in the polyacrylamide gels. Its purpose is to provide the information monomer solution. As a result, acrylamide may be the primary required to achieve reproducible, controllable polymerization. source of interfering contaminants (Dirksen and Chrambach For those users interested only in the “bare essentials,” the 1972).
    [Show full text]
  • Sucralfate Enemas
    Sucralfate Enemas Sucralfate enemas are used to treat inflammation of the rectum (the lower part of the large intestine leading to the anus); most commonly this is for radiation proctitis; bowel inflammation following radiotherapy. This treatment can help treat bleeding due to the inflammation, and can be continued for up to 24 weeks; you can stop when the bleeding stops. This fact sheet explains how you can administer the enema yourself, using a syringe and catheter. The hospital or community pharmacy can provide the Sucralfate enema, and you will need to ask your GP or practise nurse to supply the equipment you will need. Your practise nurse can help you practice preparing the enema, and could help you with administering it at home, if you find this difficult. 1. Using the syringe provided, draw up 10mls of the Sucralfate Suspension (2g) and then draw up 10mls of warm water and mix. Ensure that any excess air is expelled from the syringe. 2. Attach the catheter provided to the syringe tip and lubricate the end of the catheter with lubricating gel provided. 3. Lie on your left side with both knees bent. This position will help the flow of liquid in to the rectum and aid enema retention. 4. Position a towel underneath yourself to catch any leakage of fluid once the enema has been administered. 5. With a steady pressure, gently insert the catheter to a depth of approximately 10cm into the rectum. 6. Press down on the barrel of the syringe slowly, using a steady and even pressure, until the entire contents of the syringe have been administered.
    [Show full text]
  • Colgate Blue Minty Gel Toothpaste This Industrial Safety Data Sheet Is Not Intended for Consumers and Does Not Address Consumer Use of the Product
    APJ Colgate Blue Minty Gel Toothpaste This industrial Safety Data Sheet is not intended for consumers and does not address consumer use of the product. For information regarding consumer applications of this product, refer to the product label. Version Revision Date: SDS Number: Date of last issue: - 1.0 23.11.2016 660000003786 Date of first issue: 23.11.2016 SECTION 1. PRODUCT AND COMPANY IDENTIFICATION Product name : Colgate Blue Minty Gel Toothpaste Product code : 200000015708 : B05408280003 Manufacturer or supplier's details Company : Colgate-Palmolive Co Colgate-Palmolive Central America Region Address : Colgate-Palmolive Pty Ltd., 345 George St, Sydney, New South Wales, Australia 2000. Telephone : Consumer affairs: - AU 1800 802 307 (Mon – Fri 9 - 5) Emergency telephone number : CHEMTREC Australia +(61)-290372994 Global-CHEMTREC- +1 703-741-5970 Telefax : +50250224239500 나.Recommended use of the chemical and restrictions on use Recommended use : A formulated dentifrice. SECTION 2. HAZARDS IDENTIFICATION GHS Classification Serious eye damage/eye irri- : Category 2A tation GHS label elements Hazard pictograms : Signal word : Warning Hazard statements : H319 Causes serious eye irritation. 1 / 11 APJ Colgate Blue Minty Gel Toothpaste This industrial Safety Data Sheet is not intended for consumers and does not address consumer use of the product. For information regarding consumer applications of this product, refer to the product label. Version Revision Date: SDS Number: Date of last issue: - 1.0 23.11.2016 660000003786 Date of first issue: 23.11.2016 Precautionary statements : Prevention: P264 Wash skin thoroughly after handling. P280 Wear eye protection/ face protection. Response: P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes.
    [Show full text]
  • Bowel Preparation Instructions Fleet Enema
    66 BOWEL PREPARATION INSTRUCTIONS FLEET ENEMA Please read these instructions before you have your enema and follow carefully. If you need more advice before using the enema, please telephone the Endoscopy Unit on Tel: 01246 512197 You have been given a phosphate enema, which should be kept and used at room temperature. This is to be used on the day you are coming to hospital for your flexible sigmoidoscopy procedure. Instructions: • The enema must be given at least one hour before you leave home to attend hospital. e.g. if your appointment is at 2.00pm and you will be leaving at 1.30pm you must give the enema at 12.30pm. • To give the enema, you need to lie down on your side with both knees bent and pulled up towards your chest. • Remove the enema cap and throw it away. • Relax and gently insert the full length of the nozzle into your rectum (back passage). • Do this without using undue force. The tip of the nozzle is already lubricated to make insertion easier • Squeeze the bottle until it is completely empty. The bottle may be rolled up (like a tube of toothpaste) ensure it empties. Then gently withdraw the bottle while still squeezing to keep it rolled up. • Hold the liquid in your back passage for as long as you can (by clenching your buttocks) 66 MAKE SURE YOU ARE CLOSE TO A TOILET AS THE ENEMA WILL RESULT IN A RAPID EMPTYING OF YOUR BOWELS • Return the used enema to its carton and throw away safely in your domestic waste.
    [Show full text]
  • About Your Surgery Pre-Operative Instructions Prior to Surgery Post-Operative Instructions How to Reach Us
    www.fpminstitute.com About Your Surgery Pre-operative Instructions Prior to Surgery Post-operative Instructions How to Reach Us www.fpminstitute.com Pre-operative Instructions Please Note Patient Name: Procedure: Vaginal Colpopexy Enterocele / Rectocele Repair A physician at The Institute for Female Pelvic Medicine & Sacral Colpopexy Colpocleisis / Colpectomy Reconstructive Surgery is available for emergencies 24 hours per day. Hysterectomy Removal / Revision Uterosacral Vault Suspension InterStim® Office hours are Monday through Friday, 8 a.m. to 4 p.m. Colporrhaphy Pubovaginal Sling After hours and on weekends, you can leave non-urgent messages Other: that will be returned the next business day. For urgent situations, Surgery Date: the answering service can page the physician on call. Medical Clearance Blood work at Lab Blood work on Admit. You are required to be medically cleared for surgery by your primary care physician and/or cardiologist within 30 days of your scheduled surgery. You have been given a medical clearance form that your physician will need to complete, as well as a script for an EKG and bloodwork. Please contact your physician and schedule your medical clearance appointment for the week of (not before this www.fpminstitute.com date). If your physician sends you to a lab for bloodwork, we suggest you do this at least two to three days before your appointment, but not before the date indicated above. We will need copies of your test results and completed medical clearance form faxed to us at the number on the form at least three (3) business days prior to your surgery. If you have any questions, please contact our nursing department.
    [Show full text]
  • Injection of Stabilized Hyaluronic Acid-Based Gel of Non-Animal Origin for the Correction of Nasolabial Folds: Comparison with and Without Lidocaine
    Injection of Stabilized Hyaluronic Acid-Based Gel of Non-Animal Origin for the Correction of Nasolabial Folds: Comparison with and without Lidocaine à y à z PER HEDE´ N,PHD, DAN FAGRELL, MD, JAN JERNBECK, MD, RICHARD RYLANDER, MD, à z z ULF SAMUELSON,PHD, GABRIELLA SELLMAN, MD, AND BIRGIT STARK,PHD BACKGROUND The use of injectable hyaluronic acid–based gel of non-animal origin, manufactured using the patented NASHA technology, is well established in aesthetic facial procedures. OBJECTIVE To compare injection pain, dermal filler efficacy, and safety of NASHA-based gel with or without 0.3% lidocaine hydrochloride when administered to the nasolabial fold (NLF). METHODS Forty-three subjects seeking correction of NLFs, with moderate or severe wrinkle severity, were recruited for this split-face, double-blind, comparative study. NASHA-based gel, with or without lidocaine hydrochloride, was injected into the deep layer of the dermis and/or subcutis, of the NLF. Pain, efficacy, and safety assessments included a treatment preference question, a 100-mm visual analogue scale for pain, the Wrinkle Severity Rating Scale, and adverse event reporting. RESULTS Ninety percent of subjects (lower 95% confidence limit=76%) rated injection of NASHA- based gel with lidocaine as less painful than NASHA-based gel alone. Subjects and physicians reported no significant differences in dermal filler efficacy between the two treatments during the 12-month follow-up period. The safety profile was similar for both products. CONCLUSION NASHA-based gel with lidocaine provides a more comfortable treatment experience than NASHA-based gel alone, with equivalent efficacy and safety observed after 12 months of follow-up.
    [Show full text]
  • CLOSE up Red Gel Toothpaste
    CLOSE UPTM Red Gel Toothpaste Safety Data Sheet According To Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules And Regulations Revision Date: 04/21/2015 Date of issue: 04/21/2015 Supersedes Date: 02/25/2004 Version: 1.0 SECTION 1: IDENTIFICATION Product Identifier Product Form: Mixture Product Name: CLOSE UPTM Red Gel Toothpaste Intended Use of the Product Oral Care. Name, Address, and Telephone of the Responsible Party Company Church & Dwight 500 Charles Ewing Blvd Ewing Township, NJ 08628 T 1-800-524-1328 www.churchdwight.com Emergency Telephone Number Emergency Number : For Medical Emergency: 1-888-234-1828, For Chemical Emergency: 1-800-424-9300 (CHEMTREC) SECTION 2: HAZARDS IDENTIFICATION This product is labeled in accordance with regulations administered by the Consumer Product Safety Commission (CPSC). The use pattern and exposure in the workplace are generally not consistent with those experienced by consumers. The requirements of the Occupational Safety and Health Administration applicable to this SDS differ from the labeling requirements of the CPSC and, as a result, this SDS may contain additional health hazard information not pertinent to consumer use and not found on the product label. Classification of the Substance or Mixture Classification (GHS-US) Skin Sens. 1 H317 Full text of H-phrases: see section 16 Label Elements GHS-US Labeling Hazard Pictograms (GHS-US) : GHS07 Signal Word (GHS-US) : Warning Hazard Statements (GHS-US) : H317 - May cause an allergic skin reaction. Precautionary Statements (GHS-US) : P261 - Avoid breathing vapors, mist, or spray. P272 - Contaminated work clothing must not be allowed out of the workplace.
    [Show full text]
  • Barium Enema? Your Child’S Doctor Will Tell You If There Are Special Test to Get More Information
    9. After your child has had a bowel movement, the during the test. Bring along a book for your child to Your Child’s Care technologist will take a few more X-rays of the read during waiting periods. The Le Bonheur radiology staff wants to care large intestine without the barium. For adolescents, privacy may be their biggest for your child’s physical and emotional needs. The 10. A doctor trained in reading X-rays will study concern. Explain the test to your teen, and encourage information in this brochure will answer questions you the pictures and send the results to your him/her to ask us questions. or your child may have about the scheduled barium child’s doctor. enema, and help prepare your child for the test. Does my child have to do anything Your child’s doctor can also answer any questions How do I tell my child about the different before the test? you may have, or you can call the Le Bonheur radiology department where your child will have the barium enema? Your child’s doctor will tell you if there are special test to get more information. Please talk to your child before you come to Le things to do before your child has the test. Please call Bonheur. It will make the procedure easier for you Radiology at 901-287-7041 if you need further What is a barium enema? and your child. Assure your child that any discomfort instructions. will only last a few minutes, and that the test will A barium enema helps the doctor see how the If your child is scheduled for an air contrast barium, not hurt.
    [Show full text]